SPA

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock

Retrieved on: 
Tuesday, March 26, 2024
Mental Health, Health, Neurology, Health Technology, Clinical Trials, Pharmaceutical, Biotechnology, Sale, IGC, SPA

IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announced a $3 million strategic investment from funds managed by Bradbury Asset Management (Hong Kong) Limited (“Bradbury”), a leading asset management firm.

Key Points: 
  • IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announced a $3 million strategic investment from funds managed by Bradbury Asset Management (Hong Kong) Limited (“Bradbury”), a leading asset management firm.
  • The investment is for approximately $3 million in gross proceeds at the March 21, 2024, closing price of $0.34.
  • The completion of the private placement is subject to customary closing conditions, including approval by the NYSE.
  • Under the terms of the SPA, IGC will issue 8,823,529 shares of common stock.

BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, April 1, 2024
Neuroprotection, Research, Conference, Prejudice, Disease, SPA, ALS, Patient, Biomarker, Committee, Gene, MD, Biologics license application, Agency, Safety, Brainstorm, Poster, Therapy, Marketing, FDA, BLA, Episcopal conference, Food, Pharmaceutical industry

NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the full year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the full year ended December 31, 2023 and provided a corporate update.
  • We continue to believe that, if approved, NurOwn has the potential to be a valuable treatment option for ALS patients in need.
  • Stacy Lindborg, Ph.D., co-CEO BrainStorm commented, "We are acutely aware of the challenges faced by those afflicted with ALS.
  • In October 2023, Brainstorm announced a strategic realignment to enable accelerated development of NurOwn for the treatment of ALS.

Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline

Retrieved on: 
Wednesday, March 27, 2024
Element, Myocardial infarction, FACC, Interest, AMI, Growth, Lupus, Cardiology, SPA, Patient, Columbia University, NYU, Faculty, FAHA, MBA, FESC, Heart failure, MPH, Safety, OPUS, FDA, Autoimmune disease, Food, Hospital, Pharmaceutical industry

The focus of the event will be a discussion of its collaboration with Idorsia, Phase 3 assets selatogrel and cenerimod and key elements of the Company's pipeline.

Key Points: 
  • The focus of the event will be a discussion of its collaboration with Idorsia, Phase 3 assets selatogrel and cenerimod and key elements of the Company's pipeline.
  • The collaboration with Idorsia is a great example of Viatris' strategy in action—adding two late-stage potential blockbuster assets, selatogrel and cenerimod—and connecting Idorsia's highly productive drug development team and innovation engine with Viatris' existing infrastructure and experience.
  • The Company will review key elements of the collaboration including how Viatris can make a difference in the delivery of these assets.
  • An archived version also will be available following the live event and can be accessed at the same location for a limited time.

Enermont and Solar Power Accelerator seal a strategic deal on installation in 2024 of 15 MWp rooftop based sun energy to boost climate transition under contracted power purchase agreements

Retrieved on: 
Tuesday, March 19, 2024
EV, ECP, IPP, Power purchase agreement, Entrepreneurship, SPA, Running, C&I, Independent power producer, PPA, EPC, Professional, Renewable energy

Enermont, domiciled in Hässleholm, in south Sweden is a highly specialised EPC-contractor on PV-solar and battery installations.

Key Points: 
  • Enermont, domiciled in Hässleholm, in south Sweden is a highly specialised EPC-contractor on PV-solar and battery installations.
  • Founded in 2018, Enermont has an impressive growth trajectory and track record with a focus on quality, delivery performance, operations and capital efficiency.
  • We are running and leading an exceptionally aspirational climate transition campaign to roll out distributed roofbased solar power generation.
  • Hence, we are honoured to team up with such a highly credible and reputable ECP contractor like Enermont, says Pär-Olof Johannesson, CEO and Co-Founder, Solar Power Accelerator AB.

Stingray Introduces a New Wave of Music and Video Channels on Samsung TV Plus Across Canada, Australia, and New Zealand

Retrieved on: 
Monday, March 11, 2024
Smooth jazz, Stingray Djazz, Collection, Stingray Classica, Stingray Music, TSX, Samsung, Pulse, Stingray Naturescape, SPA, Hot Country, Hip hop music, Samsung Electronics, FAST, Music, Partnership, Nightclub

This rollout introduces a rich selection of music and video channels tailored to diverse tastes and preferences, now available to users across Canada, Australia and New Zealand on Samsung Smart TVs, Galaxy devices, and more.

Key Points: 
  • This rollout introduces a rich selection of music and video channels tailored to diverse tastes and preferences, now available to users across Canada, Australia and New Zealand on Samsung Smart TVs, Galaxy devices, and more.
  • For Canadian audiences, Stingray presents an array of channels to explore.
  • "We are incredibly excited to join forces with Samsung TV Plus, a leading FAST service with unparalleled reach in delivering free premium entertainment, to showcase our diverse portfolio of audio and video channels," said David Purdy, Chief Revenue Officer at Stingray.
  • This partnership with Samsung TV Plus underscores Stingray's commitment to expanding its reach and delivering its top-tier music and video content to a broader audience.

James River Commences Litigation Against Fleming Intermediate Holdings to Enforce Stock Purchase Agreement

Retrieved on: 
Monday, March 11, 2024
Complaint, Acquisition, Court, Sale, Fleming, SPA, Supreme court

James River will seek expedited relief from the Court to require Fleming to close the transaction.

Key Points: 
  • James River will seek expedited relief from the Court to require Fleming to close the transaction.
  • James River brings this action in response to the refusal of Fleming to complete the fully negotiated transaction that it executed in November.
  • James River will take all actions necessary to protect its interests, enforce James River’s rights under the SPA and compel Fleming to complete the transaction in accordance with its terms.
  • As long as James River continues to own JRG Re, James River will continue to operate and support JRG Re and its cedents as it has throughout its ownership.

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update

Retrieved on: 
Friday, March 8, 2024
OCUP, Research, Mydriasis, FDA, Protocol, PS, Presbyopia, Calendar, Diabetic retinopathy, Interim, Safety, DR, Diabetes, Patient, SPA, Security (finance), Ash, LPC, Pharmaceutical industry

In October 2023, Ocuphire held an End-of-Phase 2 meeting with the FDA and aligned on the registrational primary endpoint of 3-step or more worsening on binocular DRSS Person scale.

Key Points: 
  • In October 2023, Ocuphire held an End-of-Phase 2 meeting with the FDA and aligned on the registrational primary endpoint of 3-step or more worsening on binocular DRSS Person scale.
  • In February 2024, Ocuphire submitted a Special Protocol Assessment (“SPA”) to seek agreement on the clinical trial protocol and statistical analysis plan for Phase 3.
  • In September 2023, Ocuphire and Viatris, Inc. (“Viatris”) announced FDA approval of PS under the brand name RYZUMVI™ for the treatment of pharmacologically-induced mydriasis.
  • Financial Highlights for the Fourth Quarter and Full Year Ended December 31, 2023
    As of December 31, 2023, Ocuphire had cash and cash equivalents of approximately $50.5 million.

Dundee Precious Metals Announces Sale of Tsumeb Smelter for US$49 Million

Retrieved on: 
Thursday, March 7, 2024
Mining, Investment, TSX, Sale, Transaction, Government, IXM, Gold, Metal, SPA, DPM, Workforce

“We are pleased to announce the sale of the Tsumeb smelter, which is consistent with our strategic objective of focusing on our gold mining assets and simplifying our portfolio going forward.

Key Points: 
  • “We are pleased to announce the sale of the Tsumeb smelter, which is consistent with our strategic objective of focusing on our gold mining assets and simplifying our portfolio going forward.
  • We are extremely proud of the investments that we have made to transform Tsumeb’s operational and environmental performance into a specialized custom smelter with a highly skilled workforce,” said David Rae, President and Chief Executive Officer.
  • “We would like to thank the government of Namibia, the community of Tsumeb and our employees for their support over the past 13 years.
  • Cutfield Freeman & Co. Ltd. acted as financial adviser to DPM in the Transaction.

International Tribunal orders Trafigura to pay US$ 42,500,000, plus interest, to a subsidiary of Southern Peaks Mining LP

Retrieved on: 
Tuesday, March 5, 2024
Acquisition, Arbitral tribunal, Enfariné noir, Tribunal, Commerce, SPA, Property management

LIMA, Peru, March 05, 2024 (GLOBE NEWSWIRE) -- Southern Peaks Mining LP is pleased to advise that an international arbitration tribunal has ordered Urion Mining International B.V. (“Urion”) to pay its subsidiary, Ariana Management Corporation, S.A.C.

Key Points: 
  • LIMA, Peru, March 05, 2024 (GLOBE NEWSWIRE) -- Southern Peaks Mining LP is pleased to advise that an international arbitration tribunal has ordered Urion Mining International B.V. (“Urion”) to pay its subsidiary, Ariana Management Corporation, S.A.C.
  • As per the terms and conditions of the SPA, Trafigura Beheer B.V. is jointly and severally liable for the payment obligation, including interest.
  • In 2021, Ariana referred its SPA dispute with Urion to international arbitration at the Chamber of Commerce of Lima.
  • Southern Peaks Mining LP’s CEO, Mr. Adolfo Vera, commented on the Tribunal’s decision:
    “We are pleased that the Tribunal granted a proportion of our claims.

Excelerate Energy Reports Strong Full Year 2023 Results and Announces New $50 Million Share Repurchase Program

Retrieved on: 
Wednesday, February 28, 2024
Oil, Gas, Energy, Acquisition, Investment, Share repurchase, QatarEnergy, Term loan, Common stock, Adjustment, GAAP, Sequoia, SPA, Central Time, Natural gas

In January 2024, Excelerate signed a 15-year LNG Sales and Purchase Agreement (“SPA”) with QatarEnergy.

Key Points: 
  • In January 2024, Excelerate signed a 15-year LNG Sales and Purchase Agreement (“SPA”) with QatarEnergy.
  • Under the agreement, Excelerate will purchase 0.85 to 1.0 million tonnes per annum ("MTPA") of LNG from QatarEnergy on a delivered ex-ship basis beginning in January 2026.
  • As of December 31, 2023, Excelerate had $555.9 million in cash and cash equivalents, $49.4 million of letters of credit issued and no outstanding borrowings under its $350 million revolving credit facility.
  • The Excelerate Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $50 million of its outstanding Class A common stock through February 2026.